Dupont Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,374
| Closed | -$284K | – | 1046 |
|
|
2022
Q4 | $284K | Sell |
2,374
-435
| -15% | -$52K | 0.01% | 694 |
|
|
2022
Q3 | $298K | Sell |
2,809
-1,023
| -27% | -$109K | 0.02% | 762 |
|
|
2022
Q2 | $374K | Sell |
3,832
-906
| -19% | -$88.4K | 0.02% | 818 |
|
|
2022
Q1 | $444K | Buy |
4,738
+1,620
| +52% | +$152K | 0.02% | 816 |
|
|
2021
Q4 | $266K | Sell |
3,118
-3,212
| -51% | -$274K | 0.01% | 1014 |
|
|
2021
Q3 | $607K | Sell |
6,330
-2,233
| -26% | -$214K | 0.02% | 785 |
|
|
2021
Q2 | $833K | Buy |
8,563
+5,015
| +141% | +$488K | 0.02% | 712 |
|
|
2021
Q1 | $345K | Buy |
3,548
+2,399
| +209% | +$233K | 0.01% | 1103 |
|
|
2020
Q4 | $110K | Hold |
1,149
| – | – | ﹤0.01% | 1203 |
|
|
2020
Q3 | $110K | Sell |
1,149
-1,732
| -60% | -$166K | ﹤0.01% | 1188 |
|
|
2020
Q2 | $351K | Buy |
+2,881
| New | +$351K | 0.01% | 922 |
|
|
2019
Q4 | – | Sell |
-2,056
| Closed | -$185K | – | 1275 |
|
|
2019
Q3 | $185K | Buy |
+2,056
| New | +$185K | ﹤0.01% | 1109 |
|
|
2019
Q1 | – | Sell |
-3,500
| Closed | -$250K | – | 1225 |
|
|
2018
Q4 | $250K | Sell |
3,500
-9,412
| -73% | -$672K | 0.01% | 980 |
|
|
2018
Q3 | $1.59M | Buy |
12,912
+7,961
| +161% | +$979K | 0.04% | 447 |
|
|
2018
Q2 | $486K | Sell |
4,951
-4,264
| -46% | -$419K | 0.01% | 715 |
|
|
2018
Q1 | $764K | Sell |
9,215
-86,748
| -90% | -$7.19M | 0.02% | 586 |
|
|
2017
Q4 | $7.45M | Buy |
95,963
+23,466
| +32% | +$1.82M | 0.17% | 120 |
|
|
2017
Q3 | $4.44M | Buy |
72,497
+59,843
| +473% | +$3.67M | 0.1% | 203 |
|
|
2017
Q2 | $582K | Buy |
12,654
+6,734
| +114% | +$310K | 0.01% | 649 |
|
|
2017
Q1 | $256K | Sell |
5,920
-8,759
| -60% | -$379K | 0.01% | 796 |
|
|
2016
Q4 | $568K | Buy |
14,679
+12,528
| +582% | +$485K | 0.01% | 628 |
|
|
2016
Q3 | $109K | Sell |
2,151
-9,919
| -82% | -$503K | ﹤0.01% | 643 |
|
|
2016
Q2 | $549K | Buy |
12,070
+6,926
| +135% | +$315K | 0.01% | 561 |
|
|
2016
Q1 | $203K | Sell |
5,144
-22,006
| -81% | -$868K | ﹤0.01% | 609 |
|
|
2015
Q4 | $1.54M | Buy |
27,150
+3,030
| +13% | +$171K | 0.04% | 388 |
|
|
2015
Q3 | $960K | Hold |
24,120
| – | – | 0.02% | 455 |
|
|
2015
Q2 | $1.15M | Buy |
24,120
+9,000
| +60% | +$430K | 0.02% | 416 |
|
|
2015
Q1 | $600K | Sell |
15,120
-7,910
| -34% | -$314K | 0.01% | 493 |
|
|
2014
Q4 | $514K | Sell |
23,030
-9,960
| -30% | -$222K | 0.01% | 545 |
|
|
2014
Q3 | $517K | Hold |
32,990
| – | – | 0.01% | 556 |
|
|
2014
Q2 | $490K | Sell |
32,990
-5,890
| -15% | -$87.5K | 0.01% | 580 |
|
|
2014
Q1 | $626K | Sell |
38,880
-35,477
| -48% | -$571K | 0.01% | 569 |
|
|
2013
Q4 | $694K | Sell |
74,357
-11,517
| -13% | -$107K | 0.01% | 542 |
|
|
2013
Q3 | $972K | Buy |
85,874
+27,922
| +48% | +$316K | 0.02% | 489 |
|
|
2013
Q2 | $775K | Buy |
+57,952
| New | +$775K | 0.01% | 497 |
|